APA (7th ed.) Citation

AM, T., S, T., G, D. M., C, I., C, V., C, D., . . . S, D. M. (2024). Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites. European journal of medicinal chemistry, 276, 116669. https://doi.org/10.1016/j.ejmech.2024.116669

Chicago Style (17th ed.) Citation

AM, Trotta, et al. "Disulfide Bond Replacement with Non-reducible Side Chain to Tail Macrolactamization for the Development of Potent and Selective CXCR4 Peptide Antagonists Endowed with Flanking Binding Sites." European Journal of Medicinal Chemistry 276 (2024): 116669. https://doi.org/10.1016/j.ejmech.2024.116669.

MLA (9th ed.) Citation

AM, Trotta, et al. "Disulfide Bond Replacement with Non-reducible Side Chain to Tail Macrolactamization for the Development of Potent and Selective CXCR4 Peptide Antagonists Endowed with Flanking Binding Sites." European Journal of Medicinal Chemistry, vol. 276, 2024, p. 116669, https://doi.org/10.1016/j.ejmech.2024.116669.